Maximus, Inc. (NYSE:MMS) Shares Acquired by Allworth Financial LP

Allworth Financial LP increased its position in Maximus, Inc. (NYSE:MMS) by 1,638.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,495 shares of the health services provider’s stock after acquiring an additional 1,409 shares during the period. Allworth Financial LP’s holdings in Maximus were worth $116,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares during the period. Eastern Bank bought a new position in Maximus in the 4th quarter valued at about $29,000. V Square Quantitative Management LLC grew its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd bought a new position in Maximus in the 4th quarter valued at about $54,000. Finally, Quarry LP grew its position in Maximus by 48.0% in the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock valued at $95,000 after buying an additional 330 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE:MMS opened at $65.95 on Monday. Maximus, Inc. has a twelve month low of $64.53 and a twelve month high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a 50-day moving average of $73.79 and a 200-day moving average of $81.63. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of 14.18 and a beta of 0.72.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.82%. Maximus’s dividend payout ratio (DPR) is 25.81%.

Insider Activity

In other news, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the purchase, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders acquired 7,063 shares of company stock worth $502,017. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on MMS. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.